Search research articles
Contact Us
Filters
Showing results (1-10 of 29) with videos related to
Page
of 3
Sort By:
British Journal of Pharmacology
|
April 15, 2014
TRP channels and STIM/ORAI proteins: sensors and effectors of cancer and stroma cell migration
N Nielsen, O Lindemann, A Schwab
Acta Psychologica
|
November 12, 2022
Spatial-numerical associations without a motor response? Grip force says 'Yes'
A Miklashevsky, M H Fischer, O Lindemann
Psychological Research
|
October 7, 2020
Spatial-numerical associations in the presence of an avatar
C Böffel, C Herbst, O Lindemann, et al.
Plos One
|
June 29, 2023
How to not induce SNAs: The insufficiency of directional force
A Michirev, K Kühne, O Lindemann, et al.
Acta Psychologica
|
August 29, 2024
Spontaneous grip force fluctuations mirror semantic numerical magnitude processing: Larger numbers elicit larger forces
A Michirev, O Lindemann, K Kühne, et al.
Biochimica Et Biophysica Acta
|
January 18, 2015
TRPC1 regulates fMLP-stimulated migration and chemotaxis of neutrophil granulocytes
O Lindemann, C Strodthoff, M Horstmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 29, 2012
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer
Jonas Bergh, Per-Ebbe Jönsson, Elisabet Kerstin Lidbrink, et al.
Breast Cancer Research and Treatment
|
October 16, 2012
Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized 'FIRST' study
John F R Robertson, Justin P O Lindemann, Antonio Llombart-Cussac, et al.
Plos One
|
May 5, 2017
Accurate detection of low prevalence AKT1 E17K mutation in tissue or plasma from advanced cancer patients
Elza C de Bruin, Jessica L Whiteley, Claire Corcoran, et al.
Breast Cancer Research and Treatment
|
July 16, 2010
Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)
Kathleen I Pritchard, Janusz Rolski, Zsuzsanna Papai, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 29) with videos related to
Sort By:
Page
of 3
British Journal of Pharmacology
|
April 15, 2014
TRP channels and STIM/ORAI proteins: sensors and effectors of cancer and stroma cell migration
N Nielsen, O Lindemann, A Schwab
Acta Psychologica
|
November 12, 2022
Spatial-numerical associations without a motor response? Grip force says 'Yes'
A Miklashevsky, M H Fischer, O Lindemann
Psychological Research
|
October 7, 2020
Spatial-numerical associations in the presence of an avatar
C Böffel, C Herbst, O Lindemann, et al.
Plos One
|
June 29, 2023
How to not induce SNAs: The insufficiency of directional force
A Michirev, K Kühne, O Lindemann, et al.
Acta Psychologica
|
August 29, 2024
Spontaneous grip force fluctuations mirror semantic numerical magnitude processing: Larger numbers elicit larger forces
A Michirev, O Lindemann, K Kühne, et al.
Biochimica Et Biophysica Acta
|
January 18, 2015
TRPC1 regulates fMLP-stimulated migration and chemotaxis of neutrophil granulocytes
O Lindemann, C Strodthoff, M Horstmann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 29, 2012
FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer
Jonas Bergh, Per-Ebbe Jönsson, Elisabet Kerstin Lidbrink, et al.
Breast Cancer Research and Treatment
|
October 16, 2012
Fulvestrant 500 mg versus anastrozole 1 mg for the first-line treatment of advanced breast cancer: follow-up analysis from the randomized 'FIRST' study
John F R Robertson, Justin P O Lindemann, Antonio Llombart-Cussac, et al.
Plos One
|
May 5, 2017
Accurate detection of low prevalence AKT1 E17K mutation in tissue or plasma from advanced cancer patients
Elza C de Bruin, Jessica L Whiteley, Claire Corcoran, et al.
Breast Cancer Research and Treatment
|
July 16, 2010
Results of a phase II study comparing three dosing regimens of fulvestrant in postmenopausal women with advanced breast cancer (FINDER2)
Kathleen I Pritchard, Janusz Rolski, Zsuzsanna Papai, et al.
Page
of 3